EK - Local recommendations (Musculoskeletal system)
Use documents past their review date with caution
Arthritis
| Recommendation | Approval date | Review date |
| Biologics for AS_nrAxSpA_NICE TA implementation guidance | May 2017 | May 2020 |
| Certolizumab for Psoriatic Arthitis EKPG Recommendation | January 2014 | April 2021 |
| East Kent Community Rheumatology Formulary excl biologics | April 2018 | April 2021 |
| NICE TA implementation guidance – Biologics for ankylosing spondylitis and non-radiographic axial spondyloarthritis-EKPG Front Sheet | June 2017 | June 2020 |
| Use of biosimilars EKPG Recommendation | May 2015 | April 2021 |
| PR 2024-09: Infliximab without methotrexate for rheumatoid arthritis | June 2024 | June 2026 |
Soft tissue and joint disorders
| Recommendation | Approval date | Review date |
| EKPG Recommendation - Collagenase clostridium histolyticum injection (Xiapex) for Dupuytren's contracture | April 2012 | April 2021 |
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary